A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome

.

Source: Expert Opinion on Drug Metabolism and Toxicology - March 15, 2024 Category: Drugs & Pharmacology Authors: Gaia PellitteriSalvatore VersaceGiovanni MerlinoAnnacarmen NiloGian Luigi GigliMariarosaria Valentea Clinical Neurology Unit, Udine University Hospital, Udine, Italyb Department of Medicine (DMED), University of Udine, Udine, Italy Source Type: research